Literature DB >> 24440295

Selective inhibition of Leishmania donovani by active extracts of wild mushrooms used by the tribal population of India: An in vitro exploration for new leads against parasitic protozoans.

Suvadip Mallick1, Aritri Dutta1, Somaditya Dey1, Joydip Ghosh1, Debarati Mukherjee1, Sirin Salma Sultana1, Supratim Mandal1, Soumitra Paloi2, Somanjana Khatua2, Krishnendu Acharya2, Chiranjib Pal3.   

Abstract

The study was intended at evaluating the anti-proliferating effect of mushrooms used in traditional folklore of Santal tribal population in India against Leishmania donovani (MHOM/IN/83/AG83). A total of eighteen extracts, three estracts from each mushroom [(80% ethanol extracted; Fa), (water-soluble polysaccharide fraction; Fb), (polyphenolic fraction; Fc)], from six wild mushrooms were obtained. These extracts were tested against the promastigotes and amastigotes for their antileishmanial capacity. Fa fractions (250 μg/mL) of Astraeus hygrometricus and Tricholoma giganteum significantly inhibited the growth of L. donovani promastigotes and interfered in lipid biosynthesis. Moreover, both fractions induced apoptosis in promastigotes. Water soluble Fb fractions of A. hygrometricus, Russula laurocerasi, Russula albonigra, Termitomyces eurhizus, Russula delica and polyphenolic Fc fraction of R. laurocerasi were found to inhibit the replication of intracellular amastigotes in macrophages dose dependently. Significantly, 50% inhibitory concentration of the active extracts against intracellular amastigotes induced release of nitric oxide and IL-12 in murine macrophages and dendritic cells assay and also found considerably non-toxic on murine splenocytes. Results of this study can be used as a basis for further phytochemical and pharmacological investigations in the effort for search of novel anti-leishmanial leads.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-leishmanial; IL-12; Lipid synthesis; Mushroom extract and fraction; Nitric oxide

Mesh:

Substances:

Year:  2014        PMID: 24440295     DOI: 10.1016/j.exppara.2014.01.002

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  5 in total

Review 1.  Plant-derived compounds in treatment of leishmaniasis.

Authors:  A Oryan
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

2.  Successful Therapy of Murine Visceral Leishmaniasis with Astrakurkurone, a Triterpene Isolated from the Mushroom Astraeus hygrometricus, Involves the Induction of Protective Cell-Mediated Immunity and TLR9.

Authors:  Suvadip Mallick; Aritri Dutta; Ankur Chaudhuri; Debasri Mukherjee; Somaditya Dey; Subhadra Halder; Joydip Ghosh; Debarati Mukherjee; Sirin Salma Sultana; Gunjan Biswas; Tapan Kumar Lai; Pradyumna Patra; Indranil Sarkar; Sibani Chakraborty; Bhaskar Saha; Krishnendu Acharya; Chiranjib Pal
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 3.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

4.  Potential Anti-leishmanial Activity of a Semi-purified Fraction Isolated from the Leaves of Parthenium hysterophorus.

Authors:  Joydip Ghosh; Sondipon Chakraborty; Somaditya Dey; Debarati Mukherjee; Biswajyoti Sarkar; Suvadip Mallick; Aritri Dutta; Tanmoy Dutta; Soumen Bhattacharjee; Narayan Ghorai; Chiranjib Pal
Journal:  Acta Parasitol       Date:  2021-06-02       Impact factor: 1.440

5.  Induction of apoptosis by zerumbone isolated from Zingiber zerumbet (L.) Smith in protozoan parasite Leishmania donovani due to oxidative stress.

Authors:  Debarati Mukherjee; Chingakham Brajakishor Singh; Somaditya Dey; Supratim Mandal; Joydip Ghosh; Suvadip Mallick; Aabid Hussain; Ningombam Swapana; Samir Anis Ross; Chiranjib Pal
Journal:  Braz J Infect Dis       Date:  2015-11-28       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.